Biochemical non-response to obeticholic acid as a second-line therapy predicted a heightened risk for clinical events in patients with primary biliary cholangitis (PBC). Although response rates to ...
Nuclear physics, biotechnology and clinical practice have come a long way, and in the era of AI, these advances are leading to innovative solutions that are truly impacting lives. In the last two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results